Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells

Journal of Virology

Volumn 81, Issue 20, 2007, Pages 11170-11178

  Owen, Rachel E ^a,e   Yamada, Eriko ^a,f   Thompson, Catherine I ^b   Phillipson, Louisa J ^b   Thompson, Clare ^a   Taylor, Elizabeth ^a   Zambon, Maria ^c   Osborn, Helen M I ^b   Barclay, Wendy S ^b,d   Borrow, Persephone ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; NATURAL KILLER CELL RECEPTOR; SIALIC ACID; SIALIC ACID ALPHA 2,3 LACTOSE; SIALIC ACID ALPHA 2,6 N ACETYLLACTOSAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CHEMICAL INTERACTION; CYTOLYSIS; GLYCOSYLATION; HEMAGGLUTINATION; HUMAN; HUMAN CELL; INFLUENZA VIRUS; INFLUENZA VIRUS A H3N2; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS CELL INTERACTION; VIRUS RECOMBINANT;

BINDING SITES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; GLYCOSYLATION; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; KILLER CELLS, NATURAL; RECEPTORS, VIRUS; VIRUS ATTACHMENT;

ORTHOMYXOVIRIDAE;

EID: 35148875043     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01217-07     Document Type: Article

References (37)

1. Abe, Y., E. Takashita, K. Sugawara, Y. Matsuzaki, Y. Muraki, and S. Hongo. 2004. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 78:9605-9611.
2. Abed, Y., A. M. Bourgault, R. J. Fenton, P. J. Morley, D. Gower, I. J. Owens, M. Tisdale, and G. Boivin. 2002. Characterisation of two influenza A (H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the haemagglutinin gene. J. Infect. Dis. 186:1074-1080.
3. Achdout, H., T. I. Arnon, G. Markel, T. Gonen-Gross, G. Katz, N. Lieberman, R. Gazit, A. Joseph, E. Kedar, and O. Mandelboim. 2003. Enhanced recognition of human NK receptors after influenza virus infection. J. Immunol. 171:915-923.
4. Arnon, T. I., H. Achdout, N. Lieberman, R. Gazit, T. Gonen-Gross, G. Katz, A. Bar-Ilan, N. Bloushtain, M. Lev, A. Joseph, E. Kedar, A. Porgador, and O. Mandelboim. 2004. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103:664-672.
5. Arnon, T. I., M. Lev, G. Katz, Y. Chernobrov, A. Porgador, and O. Mandelboim. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2680-2689.
6. Barclay, W. S., I. M. Jones, H. M. I. Osborn, L. J. Phillipson, J. Ren, G. A. Talevera, and C. I. Thompson. 2007. Probing the receptor interactions of an H5 avian influenza virus using a baculovirus expression system and functionalised poly(acrylic acid) ligands. Bioorg. Med. Chem. 15:4038-4047.
7. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
8. Both, G. W., M. J. Sleigh, N. J. Cox, and A. P. Kendal. 1983. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J. Virol. 48:52-60.
9. Eisen, M. B., S. Sabesan, J. J. Skehel, and D. C. Wiley. 1997. Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology 232:19-31.
10. Elleman, C. J., and W. S. Barclay. 2004. The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321:144-153.
11. Fodor, E., L. Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. Garcia-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
12. Gambaryan, A., S. Yamnikova, D. Lvov, A. Tuzikov, A. Chinarev, G. Pazynina, R. G. Webster, M. Matrosovich, and N. Bovin. 2005. Receptor specificity of influenza viruses from birds and mammals: new data on involvement of the inner fragments of the carbohydrate chain. Virology 334:276-283.
13. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, Z. Zakay-Rones, A. Porgador, and O. Mandelboim. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncrl. Nat. Immunol. 7:517-523.
14. Hayman, A., S. Comely, A. Lackenby, S. Murphy, J. McCauley, S. Good bourn, and W. S. Barclay. 2006. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347:52-64.
15. Ito, T., Y. Suzuki, L. Mitnaul, A. Vines, H. Kida, and Y. Kawaoka. 1997. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 227:493-499.
16. Leung, K. N., and G. L. Ada. 1981. Induction of natural killer cells during murine influenza virus infection. Immunobiology 160:352-366.
17. Macken, C., H. Lu, J. Goodman, and L. Boykin. 2001. The value of a database in surveillance and vaccine selection, p. 103-106. In A. D. M. E. Osterhaus, N. Cox, and A. W. Hampson (ed.), Options for the control of influenza IV. Elsevier Science, Amsterdam, The Netherlands.
18. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Hushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055-1060.
19. Matrosovich, M., A. Tuzikov, N. Bovin, A. Gambaryan, A. Klimov, M. R. Castrucci, I. Donatelli, and Y. Kawaoka. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74:8502-8512.
20. Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H.-D. Klenk. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101:4620-4624.
21. Medeiros, R., N. Escriou, N. Naffakh, J. C. Manuguerra, and S. van der Werf. 2001. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 289:74-85.
22. Mochalova, L., A. Gambaryan, J. Romanova, A. Tuzikov, A. Chinarev, D. Katinger, H. Katinger, A. Egorov, and N. Bovin. 2003. Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology 313:473-480.
23. Moretta, L., C. Bottino, D. Pende, M. Vitale, M. C. Mingari, and A. Moretta. 2004. Different checkpoints in human NK-cell activation. Trends Immunol. 25:670-676.
24. Nobusawa, E., H. Ishihara, T. Morishita, K. Sato, and K. Nakajima. 2000. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 278:587-596.
25. Ohuchi, M., R. Ohuchi, A. Feldmann, and H. D. Klenk. 1997. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. 1. Virol. 71:8377-8384.
26. Ohuchi, M., R. Obuchi, and A. Matsumoto. 1999. Control of biological activities of influenza virus hemagglutinin by its carbohydrate moiety. Microbiol. Immunol. 43:1071-1076.
27. Pessino, A., S. Sivori, C. Bottino, A. Malaspina, L. Morelli, L. Moretta, R. Biassoni, and A. Moretta. 1998. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188:953-960.
28. Phillipson, L. J. 2005. Sialyl oligosaccharide glycopolymers: their synthesis and use as probes of influenza A H3N2 virus evolution. The University of Reading, Reading, United Kingdom.
29. Sirén, J., T. Sareneva, J. Pirhonen, M. Strengell, V. Veckman, I. Julkunen, and S. Matikainen. 2004. Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages. J. Gen. Virol. 85:2357-2364.
30. Sivori, S., D. Pende, C. Bottino, E. Marcenaro, A. Pessino, R. Biassoni, L. Moretta, and A. Moretta. 1999. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29:1656-1666.
31. Skoner, D. P., T. L. Whiteside, J. W. Wilson, W. J. Doyle, R. B. Herberman, and P. Fireman. 1996. Effect of influenza A virus infection on natural and adaptive cellular immunity. Clin. Immunol. Immunopathol. 79:294-302.
32. Smith, D. J., A. S. Lapedes, J. C. de Jong, T. M. Bestebroer, G. F. Rimmelzwaan, A. D. M. E. Osterhaus, and R. A. M. Fouchier. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
33. Stein-Streilein, J., and J. Guffee. 1986. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136:1435-1441.
34. Thompson, C. I., W. S. Barclay, and M. C. Zambon. 2004. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. J. Antimicrob. Chemother. 53:759-765.
35. Thompson, C. I., W. S. Barclay, M. C. Zambon, and R. J. Pickles. 2006. Infection of human airway epithelium by human and avian strains of influenza A virus. J. Virol. 80:8060-8068.
36. Vigerust, D. J., K. B. Ulett, K. L. Boyd, J. Madsen, S. Hawgood, and J. A. McCullers. 2007. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 81:8593-8600.
37. Wu, W., and G. M. Air. 2004. Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to α2,8-linked sialic acid. Virology 325:340-350.